2010

Psoriasis Vulgaris
Sponsor: LEO Pharma
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
18 Years and Older
Phase: Phase 3
Start Date: September 2010
End Date: March 2011

Acne Vulgaris
Sponsor: Dow Pharmaceutical Sciences
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients with Acne Vulgaris
12 Years and Older
Phase: Phase 2
Start Date: September 2010
End Date: December 2011

Acne Vulgaris
Sponsor: Braintree Laboratories
BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
12-45 Years
Phase: Phase 2
Start Date: November 2010
End Date: Date Here